Recall: D-1241-2015

Class II - Potentially Harmful

Class IIClassification

2015-06-30Initiated

OngoingStatus

Hospira Inc.Firm

Product

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

Reason

Crystallization; identified as calcium salt of Ketorolac

Distribution

Nationwide, Puerto Rico, Guam, Canada and Singapore

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.